This mechanism was found to function as an angiogenesis inhibitor, signifying that GAS5 could be targeted therapeutically in order to inhibit angiogenesis in non-small cell lung cancer [59] (Figure 3). The gene discussed is GAS5; the disease is non-small cell lung carcinoma.